Xilio Therapeutics, Inc.XLONASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P17
Within normal range
vs 3Y Ago
-1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-100.00%
20240.00%
20230.00%
2022100.00%
2021-40.75%
2020-343.75%
20190.00%